| Serial Number | 90879874 |
| Word Mark | AARVIK THERAPEUTICS |
| Filing Date | Thursday, August 12, 2021 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Monday, May 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 31, 2022 |
| Goods and Services | Pharmaceutical products for the prevention and treatment cancer, infectious and neurologic diseases and disorders; pharmaceutical preparations for the diagnosis and treatment of cancer, infectious and neurologic diseases and disorders; Pharmaceutical preparations, substances and compositions, namely, medical diagnostic reagents in the nature of mono-specific antibodies, bi-specific, and multi-specific antibodies, antibody-drug conjugates, T cell, NK cell, and Macrophage engaging antibodies, all for use in oncology, neurology and infectious disease diagnostics and treatment |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Scientific research for medical purposes in the field of cancer, infectious and neurologic diseases and disorders; research and development services in the field of antibodies; Scientific and technological services and research relating thereto, namely, scientific research, analysis and testing in the fields of mono-specific antibodies, bi-specific, multi-specific antibodies; antibody-drug conjugates, T cell, NK cell, and Macrophage engaging antibodies; Antibody engineering; Custom design and engineering of antibodies; Research and development of pharmaceuticals for the treatment of cancer, infectious and neurologic diseases and disorders; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Research development and establishment of testing specifications and procedures in the field of cancer research, and scientific research in the field of cancer diagnosis and treatment; Providing scientific research information in the field of cancer research, and providing scientific research information in the field of cancer diagnosis and treatment |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 4, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 4, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aarvik Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Hayward, CA 94544 |
| Party Name | Aarvik Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Fremont, CA 94555 |
| Event Date | Event Description |
| Monday, August 16, 2021 | NEW APPLICATION ENTERED |
| Thursday, March 24, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 4, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 10, 2022 | ASSIGNED TO EXAMINER |
| Thursday, March 17, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, March 17, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, March 17, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 23, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 23, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, March 26, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 30, 2022 | ASSIGNED TO LIE |
| Wednesday, April 20, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 31, 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, April 12, 2022 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, April 13, 2022 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, April 20, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, April 20, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 20, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, April 23, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 11, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 31, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 26, 2022 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, May 31, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 31, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, May 31, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, May 31, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, July 28, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, October 17, 2022 | NEW NOA TO ISSUE |
| Tuesday, November 29, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, January 25, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 25, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, January 25, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, November 28, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, November 30, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 27, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, May 27, 2024 | SOU EXTENSION 3 FILED |
| Monday, May 27, 2024 | SOU EXTENSION 3 GRANTED |
| Tuesday, May 28, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 28, 2023 | SOU EXTENSION 2 FILED |
| Friday, January 27, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 28, 2023 | SOU TEAS EXTENSION RECEIVED |